Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock

Acta Anaesthesiologica Scandinavica

Volumn 58, Issue 5, 2014, Pages 525-533

  Andersen, M G ^a   Hvas, C L ^a   TOnnesen E ^a   Hvas, A M ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; THROMBIN; THROMBOCYTE CONCENTRATE; ANTICOAGULANT AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COAGULOMETER; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; BIOSYNTHESIS; BLOOD; BLOOD CELL COUNT; BLOOD COMPONENT THERAPY; COMPLICATION; DISSEMINATED INTRAVASCULAR COAGULATION; HEMORRHAGE; HEMORRHAGIC DISORDERS; INTENSIVE CARE; MIDDLE AGED; PROCEDURES; SEVERITY OF ILLNESS INDEX; THROMBOPHILIA; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD CELL COUNT; BLOOD COAGULATION TESTS; BLOOD COMPONENT TRANSFUSION; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMORRHAGE; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; THROMBELASTOGRAPHY; THROMBIN; THROMBOPHILIA;

EID: 84899084059     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12290     Document Type: Article

References (31)

1. Levi M, Opal SM,. Coagulation abnormalities in critically ill patients. Crit Care 2006; 10: 222.
2. Gajic O, Dzilk WH, Toy P,. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm? Crit Care Med 2006; 34: S170-173.
3. Levi M,. The coagulant response in sepsis. Clin Chest Med 2008; 29: 627-642.
4. Hook KM, Abrams CS,. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients. Clin Transl Sci 2012; 5: 85-92.
5. Segal JB, Dzik WH,. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-1425.
6. Dzik WH,. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004; 3: 324-330.
7. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D,. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15: R108.
8. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW,. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
9. Brummel KE, Paradis SG, Butenas S, Mann KG,. Thrombin functions during tissue factor-induced blood coagulation. Blood 2002; 100: 148-152.
10. Ganter MT, Hofer CK,. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-1375.
11. Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A,. Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Intensive Care Med 2012; 38: 1326-1335.
12. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM,. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009; 13: R42.
13. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Béguin S,. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-253.
14. Petros S, Kliem P, Siegemund T, Siegemund R,. Thrombin generation in severe sepsis. Thromb Res 2012; 129: 797-800.
15. Bone RC, Sibbald WJ, Sprung CL,. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481-1482.
16. Bernard GR, Vincent JL, Laterre P, Larosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Gerber GE, Helterbrand JD, Ely EW, Fisher CJ Jr., Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation. J Chronic Dis 1987; 40: 373-383.
18. Le Grall J, Lemeshow S, Saunlier F,. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE,. Apache-II-A severity of disease classification-system. Crit Care Med 1985; 13: 818-829.
20. Vincent JL, Moreno R, Takala J, Willatts S, DeMendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG,. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-710.
21. Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP,. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006; 135: 220-227.
22. Brenner T, Schmidt K, Delang M, Mehrabi A, Bruckner T, Lichtenstern C, Martin E, Weigand MA, Hofer S,. Viscoelastic and aggregometric point-of-care testing in patients with septic shock-cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand 2012; 56: 1277-1290.
23. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M, On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
24. Romlin BS, Wahlander H, Berggren H, Synnergren M, Baghaei F, Nilsson K, Jeppsson A,. Intraoperative thromboelastometry is associated with reduced transfusion prevalence in pediatric cardiac surgery. Anesth Analg 2011; 112: 30-36.
25. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA,. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-319.
26. Lier H, Vorweg A, Hanke A, Görlinger K,. Thromboelastometry guided therapy of severe bleeding. Hamostaseologie 2013; 33: 51-61.
27. Vlaar APJ, in der Maur AL, Binnekade JM, Schultz MJ, Juffermans NP,. A survey of physicians' reasons to transfuse plasma and platelets in the critically ill: a prospective single-centre cohort study. Transfus Med 2009; 19: 207-212.
28. Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC,. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006; 10: R160.
29. Rivard GE, Brummel-Ziedins KE, Mann KG, Fan L, Hofer A, Cohen E,. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3: 2039-2043.
30. Adamzik M, Langemeier T, Frey UH, Gorlinger K, Saner F, Eggebrecht H, Peters J, Hartmann M,. Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 2011; 35: 339-342.
31. Ostrowski SR, Windelov NA, Ibsen M, Haase N, Perner A, Johansson PI,. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. J Crit Care 2013; 28: e1-11.